Belgaum Turmeric (Curcuma longa)
Belgaum Turmeric is a cultivar of Curcuma longa grown in the Karnataka region of India, valued agriculturally for its high-yielding traits and potential curcuminoid content including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. No cultivar-specific clinical research has isolated Belgaum Turmeric's effects from broader Curcuma longa data, making evidence-based health claims for this variant premature.
Origin & History
Belgaum Turmeric is a regional cultivar of Curcuma longa L., specifically cultivated in the Belgaum district of Karnataka, India, thriving in warm, humid conditions with clayey loam soils at elevations up to 1500m. The plant is propagated via rhizomes planted after pre-monsoon showers and harvested after 7-10 months for processing into powder or extracts.
Historical & Cultural Context
Curcuma longa has been historically used as a condiment for coloring, flavoring, and medicinal purposes. However, no specific traditional medicine systems or indications are documented for the Belgaum cultivar variant in the available sources.
Health Benefits
• No specific health benefits documented for Belgaum Turmeric cultivar (evidence quality: absent) • General Curcuma longa benefits cannot be confirmed for this specific variant without cultivar-specific research • High-yielding genotypes noted for potential curcuminoid content, though concentrations unspecified • Traditional medicinal uses referenced for Curcuma longa species but not verified for Belgaum variant • No clinical trials available to support health claims for this specific cultivar
How It Works
Curcumin, the primary polyphenol in Curcuma longa cultivars including Belgaum Turmeric, inhibits NF-κB signaling by blocking IκB kinase (IKK) activation, thereby reducing transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Curcumin also modulates the Nrf2-Keap1 pathway, upregulating antioxidant response elements and enzymes like heme oxygenase-1 (HO-1) and glutathione-S-transferase. However, these mechanisms are established for curcumin generally and have not been confirmed in assays using Belgaum-specific cultivar extracts with verified curcuminoid concentrations.
Scientific Research
No human clinical trials, RCTs, or meta-analyses specific to Belgaum Turmeric were found in the research dossier. The provided sources focus solely on agricultural cultivation practices without any PMIDs or clinical evidence for this cultivar variant.
Clinical Summary
No randomized controlled trials or observational studies have been conducted specifically on Belgaum Turmeric as a distinct cultivar. General Curcuma longa research includes trials on standardized curcumin extracts (typically 500–1000 mg/day) showing modest reductions in CRP and IL-6 in populations with metabolic syndrome and osteoarthritis, but these cannot be extrapolated to Belgaum Turmeric without confirmed curcuminoid profiling of this cultivar. Agricultural studies from India have noted Belgaum-type genotypes among high-yielding accessions, but curcuminoid percentages specific to this cultivar remain inconsistently reported. The overall evidence base for Belgaum Turmeric as a distinct therapeutic ingredient is currently absent.
Nutritional Profile
Belgaum Turmeric (Curcuma longa) is a regional cultivar grown predominantly in the Belgaum (Belagavi) district of Karnataka, India. While cultivar-specific compositional analyses are limited, its nutritional profile can be reasonably estimated based on general Curcuma longa rhizome data and regional agronomic reports noting it as a high-yielding genotype. **Macronutrients (per 100 g dry weight, approximate):** • Carbohydrates: 60–70 g (primarily starch, ~40–50 g; dietary fiber ~18–25 g, of which soluble fiber ~2–5 g) • Protein: 6–9 g (contains notable levels of glutamic acid, aspartic acid, and leucine) • Fat: 5–10 g (predominantly oleic acid, palmitic acid, linoleic acid; volatile oil fraction ~3–5% contributing aromatic terpenoids such as ar-turmerone, turmerone, and zingiberene) • Moisture (fresh rhizome): 75–85%; dry powder typically ≤10%. **Curcuminoids (primary bioactive compounds):** • Total curcuminoid content estimated at 2–5% of dry weight, though Belgaum cultivar-specific concentrations remain unconfirmed in peer-reviewed literature. Breakdown typically: – Curcumin (diferuloylmethane): ~60–75% of total curcuminoids (~1.5–3.5 g/100 g dry weight) – Demethoxycurcumin: ~15–25% of total curcuminoids – Bisdemethoxycurcumin: ~5–15% of total curcuminoids • Bioavailability of curcuminoids is inherently low (<1% oral absorption) due to rapid hepatic metabolism and poor aqueous solubility; co-administration with piperine (from black pepper) may enhance bioavailability by ~2000%. **Minerals (per 100 g dry weight, approximate):** • Potassium: 2000–2500 mg • Iron: 40–55 mg (non-heme; bioavailability ~5–12%, enhanced by vitamin C co-ingestion) • Manganese: 15–25 mg • Calcium: 150–200 mg • Magnesium: 190–250 mg • Phosphorus: 250–300 mg • Zinc: 4–5 mg • Copper: 0.5–1.0 mg • Sodium: 30–40 mg • Selenium: trace amounts (~4–6 µg). **Vitamins (per 100 g dry weight, approximate):** • Vitamin C (ascorbic acid): 25–30 mg (degrades significantly during drying/processing) • Vitamin B6 (pyridoxine): 1.5–2.0 mg • Niacin (B3): 4–5 mg • Riboflavin (B2): 0.2–0.3 mg • Folate (B9): ~20–40 µg • Vitamin E (tocopherols): 3–4 mg • Vitamin K: ~13–14 µg • Vitamin A: minimal, though yellow pigmentation is due to curcuminoids, not carotenoids. **Other Bioactive Compounds:** • Essential/volatile oils: 3–5% (ar-turmerone ~25–35% of oil, α-turmerone ~18–25%, β-turmerone ~12–18%, zingiberene ~5–8%, α-phellandrene, 1,8-cineole, sabinene in smaller fractions) • Polysaccharides (ukonan A, B, C, D): immunomodulatory arabinogalactans, concentrations not well-quantified for this cultivar • Peptides: turmerin (~0.1% of dry weight), a water-soluble antioxidant peptide • Phenolic acids: ferulic acid, caffeic acid, vanillic acid in minor concentrations (~0.01–0.1%) • Resin content: ~5–8%. **Bioavailability Notes:** The lipophilic nature of curcuminoids limits gastrointestinal absorption. The volatile oil fraction (particularly turmerones) present in whole turmeric may modestly improve curcumin bioavailability compared to isolated curcumin extracts. Fat-soluble compounds benefit from consumption with dietary lipids. The high fiber content may influence mineral absorption through phytate interactions, though turmeric is typically consumed in small culinary quantities (2–5 g/day), making absolute nutrient contributions modest in practical dietary contexts. **Caveat:** No cultivar-specific nutritional analysis for Belgaum Turmeric has been identified in published literature. Values are extrapolated from general Curcuma longa composition data and should be interpreted cautiously pending cultivar-specific verification.
Preparation & Dosage
No clinically studied dosage ranges are available for Belgaum Turmeric. Standard forms, extracts, or standardization details have not been established through research. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Insufficient research to recommend synergistic ingredients
Safety & Interactions
Curcuma longa preparations are generally recognized as safe at culinary doses, but concentrated curcumin supplements at 4–8 g/day have been associated with gastrointestinal disturbances including nausea, diarrhea, and increased intestinal permeability in some individuals. Curcumin inhibits CYP3A4 and CYP2C9 enzyme activity, potentially elevating plasma levels of drugs such as warfarin, tacrolimus, and certain statins, requiring caution with concurrent use. High-dose curcumin is not recommended during pregnancy due to its potential to stimulate uterine contractions, and individuals with gallstones or bile duct obstruction should avoid concentrated turmeric supplements as curcumin increases bile production. Because Belgaum Turmeric lacks a defined standardized extract, actual curcuminoid dose delivered per serving is uncertain, complicating safety guidance.
